EUCTR2020-001793-30-DK进行中（未招募）1 期
Preventing Disease Aggravation in COVID-19 by high dose Vitamin D: a randomized trial (COVIT-D) - COVIT-D
Copenhagen University Hospital of Bispebjerg0 个研究点目标入组 480 人开始时间: 2020年5月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1 Age>=50 years
- •2 Positive test for SARS-COV-2
- •3 Signed informed Consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 380
排除标准
- •1) Need for immediate hospital admission
- •2) Known hypercalcemia or hyperparathyroidism
- •3) Significant kidney disease needing dialysis
- •4) Known kidney stone or nephrocalcinosis
- •5) Pregnancy or no-anti-conception in fertile women*
- •6) Regular user of supplemental Vitamin D (>=20 µg /day > one month) or
- •7) Known intolerance to Vitamin D
研究者
相似试验
进行中（未招募）
2 期
COVID-19 Prevention of worsening of symptoms in asymptomatic to mild patients by combined use of kakkonto and hochuekkito:Exploratory open-label randomized controlled trialCOVID-19JPRN-jRCTs041200072Ogawa Keiko100
尚未招募
3 期
Prevention and treatment for covid-19 associated severe pneumonia in The Gambia: a randomized clinical trial (PaTS-COVID) COVID-19PACTR202101544570971Medical Research Council Unit The Gambia at LSHTM1,200
已完成
不适用
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trialCOVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000557932AProf Dr Karin Ried446
招募中
1 期
Therapies to prevent progression of COVID-19 in outpatients: The 'Primary Care Australian COVID-19 Therapeutics' (PACT) TrialACTRN12622000386730AProf Dr Karin Ried300
撤回
不适用
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial - Stage 2COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12622000309785AProf Dr Karin Ried200